by Paige Boldt on 11/29/2013
In November of this year alone, the FDA recalled 13 drugs or devices. This number does include companies that agreed to voluntarily recall their products through the FDA. The drugs and devices recalled this month include unsterile products, unapproved drugs, and defective products.
Most of the drugs recalled over the last month were unapproved dietary supplements. The infamous Fen Phen diet drug litigation taught us that dietary supplements often have long lasting and dangerous side effects. The FDA must be vigilant in finding these dangerous drugs and taking them off of pharmacy shelves.
The FDA recalled the following drugs and devices this month alone:
Babies R Us, Care One and more – acetaminophen infant liquid dropper
Vega ONE – an unapproved drug/dietary supplement
OxyElite Pro – a dietary supplement associated with serious liver damage or acute liver failure
VitaliKOR – an unapproved drug/dietary supplement
Nature’s Pharmacy and Compounding Center – unsterile products in the form of an injectable drug or eyedropper
Medtronic, Inc. – defective cardiac guidewires
Jobbers Wholesale – an unapproved drug/dietary supplement
RezzRx – an unapproved drug/dietary supplement
Tendex – an unapproved drug/dietary supplement
Deseo Rebajar Inc. – an unapproved drug/dietary supplement
Medtronic, Inc. – Viscocel and Viscocel Plus, distributed in the U.S. without FDA approval, and were released with sterility and biocompatibility issues
Baxter International, Inc. – particulates found in 5% Dextrose Injections
FreeStyle and FreeStyle Lite – defective blood glucose tests
For a full list of items recalled by the FDA, including food products, please see their website.
If you or a loved one has been injured by a defective device or irreparably harmed by a defective drug, please contact us immediately. Our team of lawyers has specialized in representing those who have been severely injured by recalled drugs and devices. You can also visit our dedicated pharmaceutical and medical device litigation website for more information.blog comments powered by Disqus